Inogen (INGN)
(Delayed Data from NSDQ)
$9.62 USD
-0.08 (-0.82%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $9.62 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth A Momentum A VGM
Income Statements
Fiscal Year end for Inogen, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 316 | 377 | 358 | 308 | 362 |
Cost Of Goods | 189 | 224 | 182 | 170 | 190 |
Gross Profit | 127 | 154 | 176 | 138 | 172 |
Selling & Adminstrative & Depr. & Amort Expenses | 236 | 239 | 167 | 150 | 152 |
Income After Depreciation & Amortization | -109 | -85 | 9 | -12 | 20 |
Non-Operating Income | 7 | 2 | -1 | 7 | 4 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -102 | -83 | 9 | -5 | 24 |
Income Taxes | 0 | 1 | 15 | 1 | 3 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -102 | -84 | -6 | -6 | 21 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -102 | -84 | -6 | -6 | 21 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -91 | -62 | 31 | 7 | 34 |
Depreciation & Amortization (Cash Flow) | 18 | 24 | 22 | 19 | 14 |
Income After Depreciation & Amortization | -109 | -85 | 9 | -12 | 20 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 23.18 | 22.85 | 22.49 | 21.98 | 22.24 |
Diluted EPS Before Non-Recurring Items | -4.42 | -1.15 | -0.28 | -0.27 | 1.07 |
Diluted Net EPS (GAAP) | -4.42 | -3.67 | -0.28 | -0.27 | 0.94 |
Fiscal Year end for Inogen, Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 88.77 | 78.03 | 75.90 | 83.97 | 83.64 |
Cost Of Goods | 46.03 | 43.65 | 47.74 | 50.20 | 49.59 |
Gross Profit | 42.74 | 34.37 | 28.16 | 33.76 | 34.04 |
SG&A, R&D, and Dept/Amort Expenses | 49.81 | 50.65 | 57.14 | 80.49 | 45.81 |
Income After SG&A, R&D, and Dept/Amort Expenses | -7.07 | -16.28 | -28.98 | -46.73 | -11.77 |
Non-Operating Income | 1.47 | 1.55 | 1.89 | 1.40 | 1.98 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -5.60 | -14.73 | -27.09 | -45.32 | -9.79 |
Income Taxes | -0.01 | -0.15 | -0.53 | 0.40 | 0.04 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -5.59 | -14.58 | -26.56 | -45.72 | -9.83 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -5.59 | -14.58 | -26.55 | -45.72 | -9.83 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 23.62 | 23.40 | 23.31 | 23.23 | 23.15 |
Diluted EPS Before Non-Recurring Items | -0.24 | -0.62 | -1.14 | -1.97 | -0.42 |
Diluted Net EPS (GAAP) | -0.24 | -0.62 | -1.15 | -1.97 | -0.42 |